iOS app Android app More

Weight Loss Drug, Contrave, Rejected By FDA

The Associated Press   02/ 1/11 09:47 AM ET   AP

Weight Loss Drug

DIET DRUG REJECTED: The Food and Drug Administration has declined to approve an experimental weight loss drug called Contrave, a surprising rejection to what many analysts expected to be the first new diet drug in a decade.

QUESTIONS OF THE HEART: The FDA asked Contrave to conduct an additional study focused on the drug's heart side effects, a long-standing safety issue with weight loss medications.

FUTURE UNCERTAIN: FDA's request sent shares of drugmaker Orexigen Therapeutics tumbling. Orexigen Therapeutic said the company would have to raise additional money to complete the study, which would likely take years to conduct.

FOLLOW HUFFPOST HEALTH

Filed by Nicholas Miriello  |